{
    "id": "dlv4wclyolvuexkhd2vj6sszpfn27rh3",
    "title": "Using Electronic Medical Records to advance genomic medicine",
    "info": {
        "author": [
            "Joshua C Denny, School of Medicine, Vanderbilt University"
        ],
        "published": "July 21, 2014",
        "recorded": "May 2014",
        "category": [
            "Top->Medicine"
        ]
    },
    "url": "http://videolectures.net/mdo2014_denny_genomic_medicine/",
    "segmentation": [
        [
            "This is a slide that we use a lot of the interval.",
            "It is from The New Yorker in 2000 and here we have a lady presenting her sequence on a piece of paper which I think is probably not going to be.",
            "We're doing to a pharmacist who we I think, looks rather befuddled, and array of medications kind of Askew on the floor as well.",
            "So kind of representing some of the challenges here, even a decade before we started to think about actually doing this.",
            "So how do we actually move this towards reality?",
            "And so we start with."
        ],
        [
            "Foundation of biomedical research.",
            "Ann, I think what I'm going to demonstrate today, it is really a focus on information technology and the importance of that as well.",
            "And then our model has been to really use the healthcare system as a system for discovery and then the important aspect of that is to adapt the healthcare system as you learn new data to revise and incorporate and obviously feedback into your research are doing and the IT solutions you create."
        ],
        [
            "So in everything I'm going to talk about today, the electronic health Record or HR is feeding discovery an implementation.",
            "So on the left we have the discovery side and that system that we're going to talk about uses a repository called Bio View, which is a D identified DNA repository for which all the phenotypic information essentially comes from the electronic health record.",
            "On the other side is implementation ARM, which will get in towards the latter half of the talk.",
            "That system is called predict.",
            "Where we do CLIA certified, which is the US based validation for laboratory testing.",
            "And then we have integrated decision support in the HR.",
            "This is in the clinical record.",
            "The two systems are separated and we don't know what happens in Bio View.",
            "We don't see that in the clinical side.",
            "So these are two sides of this talk and discovering implementation."
        ],
        [
            "Have you as an opt out DNA Biobank relies on the principle of establishing the code of federal regulations in the US that allows you to use deidentified samples for research.",
            "We, in addition to that, have an opt out clause and it was guided by four years of work before we started Bio View with surveys with discussions with the federal government and focus groups as well as discussions with ethicist and lawyers.",
            "And the model is that we have before above the signature line in this consent to treatment form that everyone signs in a yearly basis that says we can bill your insurance company and that sort of thing that they say that they have to check this box in order to not be part of the DNA biobank In addition, there are signs there.",
            "We've surveyed how many people are aware of the system as well.",
            "And."
        ],
        [
            "This is now an electronic screen and has been for the last few years.",
            "Our survey suggested that the opt out rate would be about 5 to 10% per year.",
            "It's been about that through the life of the program.",
            "The lifetime opt out rate is about 15% and we treat at once.",
            "Opt out isn't always opt out, assuming that maybe they just forget to check the form in subsec."
        ],
        [
            "Years, so the models we take the medical record we put the medical record number through a one way hash with the seed, which which is a unidirectional mapping.",
            "So we can't go backwards with it, and then we scrub all the personal health identifiers from the medical record and that is what we call a synthetic derivative.",
            "It has about 2.2 million records and we can update it regularly because the hash always takes the same number forward.",
            "Similarly, we have a clinical blood sample that's scheduled to be discarded.",
            "We check to see if they are eligible, meaning they haven't opted out.",
            "We also exclude a random percentage of people each day so that we don't know for sure, even if you haven't opted out, that you're in the system and then we would extract the DNA from that and bank that and currently by of you has about 180,000 DNA samples."
        ],
        [
            "The creating the synthetic driven in the sources of information we have is quite a lot, and this is actually simplified to the data sources we use.",
            "Most of them come from the medical record we have the laboratory that radiology test.",
            "These sorts of things electronic in some cases back into the 1980s.",
            "We have clinical notes, full text notes robustly across inpatient outpatient since the early 2000s, and we actually go further back than that in a lot of sources, and we have electronic prescribing.",
            "In our hospital since the 1990s and then we also combine an external registry such as tumor registries, cardiothoracic registries that are maintained on a research basis, and we can map those in as well.",
            "We need to do things to structure this data better than what would happen by default, and so we employ techniques that we've developed in House such as natural language processing which can identify, for instance, medication names, doses, routes, frequencies from free text documents.",
            "We can also map concepts like congestive heart failure in CHF and disambiguate weather.",
            "CHF means congestive heart failure or Crimean hemorrhagic fever, which doesn't happen too often in the United States, but we can.",
            "We can do those sorts of mappings as well.",
            "We can also determine what happened to the patient or to the mom.",
            "All that stuff from the natural language and then we can feed that into structured databases for querying subsequently.",
            "When we started this."
        ],
        [
            "We decided we needed a demonstration project to show it actually worked and this is we picked 5 diseases with 21 genetic variants at that time were known.",
            "We genotyped the first 10,000 patients in the Bio View and then we used electronic algorithms to find patients with those diseases.",
            "Red squares represent the public odds ratios for these snip phenotype combinations.",
            "The blue diamonds represent the odds ratios we found in Bio View.",
            "Notably, most of the confidence intervals overlap.",
            "We didn't have any snip phenotype associations that went the opposite direction, thinking they were protected versus risk factor, and depending on how you do statistical analysis, what kind of genetic model you assume we replicate 8 to 9 of the 21 associations.",
            "I've note we were underpowered for almost all these associations, and it highlights one of the challenges to doing genomic work is at L. You know that you need large sample sizes and 10,000 patients of a General Medical accrual situation was not a lot of the time.",
            "For instance, we had 66 patients with multiple sclerosis.",
            "So what we found."
        ],
        [
            "In this process of of, how do we find who has what disease?",
            "Was that it requires multiple sources of information?",
            "So we start with billing codes which are kind of necessary but not sufficient, and then we overlay on top of it.",
            "Things like clinical notes and natural language processing.",
            "Medication data is very helpful too, as a marker of both disease status and severity of disease and then laboratory and test results are often important as well.",
            "And the general process is some sort of algorithm combining these.",
            "Usually it's kind of Boolean logic and or not.",
            "Kind of combinations and doing things like counts and sometimes temporal relationships allow us to get it true cases.",
            "We start with identifying a phenotype of interest.",
            "We find that it's an iterative process where we think through what the phenotype should look like, and we manually review a set of records.",
            "Then we evolve our algorithm until we get a sufficient positive friction value.",
            "Reviewing different sets of cases each time.",
            "We don't just test the same patients each time to avoid what we've called over fitting in the machine learning world.",
            "And then we deploy in our DNA biobank and we can also deploy those and other bio banks as well.",
            "We've shown these algorithms are generally portable to other electronic health record systems and then we perform genetic Association tests.",
            "Development of the phenotype algorithm becomes the arduous part that takes the most time in today's analysis and that can take 6 to 18 months to get that right."
        ],
        [
            "We are part of a large network called the Emerge Network Electronic Medical Records in Genomics.",
            "It's funded by national Human Genome Research Institute.",
            "It now includes rtinsights across the US and there are other sites in both the US in the world that have electronic medical records linked to DNA biobanks.",
            "Our goals and emerge were initially to perform GWAS is based on a char data.",
            "It is extended to implement as well."
        ],
        [
            "That one of these studies we've done many of them, but one that I'll highlight was the first project that used just leftover genetic data and populations of patients that had been genotyped for other reasons.",
            "So we picked a relatively common phenotype, autoimmune hypothyroidism, and we look for those amongst people that were genotyped for things like cardiac conduction or dementia, cataracts.",
            "These different phenotypes across these five different emerged sites.",
            "We developed an algorithm at Vanderbilt.",
            "Then we distributed to the other.",
            "Emerge sites at that time there were total of five, and they implemented the same algorithm and validated it and it worked well at all five sites.",
            "There is one outlier, an that with a positive value in the mid 80s and that was due to the fact that they had a lot of patients in their population that were sort of flying in for subspecialty care as opposed to getting general routine care at center.",
            "We found a novel."
        ],
        [
            "No, it's a thyroid transcription signal called Foxy one on chromosome 9 that was associated with hypothyroidism and and this was replicated in a subsequent population and it's been replicated by subsequent jiwa."
        ],
        [
            "This summarizes some of the other Jiwa says we have been done.",
            "The bold phenotypes represent phenotypes for which we had genome wide significant signals.",
            "The ones with the new stars beside them represent ones that we had novel findings for those phenotypes.",
            "In addition to these 20 or so phenotypes I've listed there an additional 30 G boss is in progress as part of the Merge 2.",
            "And yesterday's."
        ],
        [
            "Presentation talked about the PCs Key Nine story and I wanted to just highlight the the ability to do these kinds of studies, potentially very rapidly in the HR.",
            "So in yesterday's presentation of Keena, we heard about the rare variants in PCs.",
            "Canine influencing people with very low LDL levels and then for being protective against cardiac events.",
            "So if you look at the distribution of LDL values in Bio view, we find that we actually have 150 people.",
            "They have LDLS less than 50 amongst people that actually have genetic data, so this shows you the distribution of the LDL values, and then if you do, we've done our very large population with the this exome chip, which looks at coding variants and happens to have the R 46 L variant, which was the stronger signal in that New England Journal paper that he presented yesterday.",
            "An if you look at just taking the general population, we genotyped, 150 of them had these very low LDL values.",
            "You can see that we very strongly replicate.",
            "That known signal with PCs K9 in a population that was not genotyped for this purpose."
        ],
        [
            "So that highlights the ability to do this kind of study on the HR.",
            "We've moved on to look at G. Watts is with.",
            "For drug response phenotypes, this was called our Vesper project as part of a grant was called a Grand opportunities grant during the bolus of funding that went into the NIH and our goal was to sequence or sorry Geno, type through juos level genotyping.",
            "About 10,000 people within that we were able to identify 31 pharmacogenetic traits to investigate and we developed phenotype algorithms for these different algorithms.",
            "The first 2.",
            "Womans we looked at in greenware replications of known associations.",
            "We talked a lot about warfare in this morning.",
            "And computer goes into effect as well, and then the rest are discovered phenotypes, notably amongst those phenotypes 5th."
        ],
        [
            "5% of the cases or controls were also participated in another phenotype, so that shows the efficiency of using Jiwa samples.",
            "I'm sorry EMR samples because they can participate in multiple phenotypes as one might expect, 'cause we all often are accrued different diseases overtime.",
            "If you look at capital grille Pickles, a prodrug is activated by CYP 217, primarily in the two Oxo, clopidogrel and studies have shown that two C 19 poor metabolizers aren't increased likelihood of having recurrent cardiovascular events.",
            "We developed an algorithm that did require some manual review to assure compliance with clopidogrel at the time of the subsequent event.",
            "Nonetheless, our algorithm was fairly accurate and you can see and certainly speed up the process of finding these patients.",
            "You can see that poor in metabolizers, where decrease incidence for having cardiovascular events similarly in reference to."
        ],
        [
            "Excellent talk this morning and warfare and I wanted to highlight some of the work we've done with your friend.",
            "This shows the percent variation that we are able to explain with different algorithms using EMR derived algorithm and what we found is that the clinical genomic algorithms for European Americans routinely did better than the clinical algorithms.",
            "But in African Americans, as you might expect, there's more similarity between the genetic algorithms and the clinical algorithms.",
            "If you expand the number of variants, you get an improved.",
            "Result.",
            "This shows two phenotypes for which we have new discoveries."
        ],
        [
            "Which both have some degree of replication.",
            "ACE inhibitors, one of the most common side effects, is cough, and we identified a significant signal there which is also associated with asthma.",
            "These samples are adjusted for asthma and heparin induced.",
            "Armed with Sandy pina.",
            "Very rare but severe outcome with high morbidity that is a T cell receptor gene.",
            "And Interestingly you have to be recessive homozygote to have the increased risk of the effect."
        ],
        [
            "So this tells you the idea of doing jiwa's in the electronic medical record.",
            "There's also the ability to do what we call Phenome Wide Association study, which does the inverse study, starting with the genotyped looking at many phenotypes and to do this really requires a densely phenotype record, something we have in electronic health records, but are not necessarily common observation.",
            "ULL studies.",
            "So as a large scale study of this, if you look at all the Geno types."
        ],
        [
            "Discovered through G was there at this time when we did the study, there were about 3100 snips that prior associations.",
            "If you map those two disease phenotypes available in the HR at 751 individual snips and phenotypes had significant associations, and we look for replication using the HR.",
            "We also looked at these for new discoveries."
        ],
        [
            "This shows a replication data.",
            "Each point represents a single snip associated with a given phenotype.",
            "Overall, testing 86 phenotypes and what you can see is we're able to replicate meaning to the right of that light blue line.",
            "A number of snip phenotype Association pairs across a number of different disease categories in this very rapid phenotype model using FiOS, the phenotypes aren't as accurate as the ones that we do in other methods where we carefully design it, but it allows us to quickly survey for new associations.",
            "Overall, we represent replicated 210 of those 751.",
            "If you look at those for which we had adequate case sizes, we replicated 51 out of 77 of the phenotypes."
        ],
        [
            "If you look at all the results we found on these 3000 snips, these are the results mapped to chromosome location, each diamond representing a single unique phenotype with that Association.",
            "So what you see is there differential pleiotropy that we have found at different parts of the genome and different locations and snips which we would expect to find the blue represent new associations that represent things that have been discovered before that we didn't replicate in green represent prior discoveries that we did.",
            "Replicate and if I just zoom in a couple locations to, llamas were first transcriptase.",
            "At the time was known associations glioma.",
            "We found associations with separated keratosis and leukoplakia and."
        ],
        [
            "And one of the most pleiotropic snips was IRF 4, which was done in discovered.",
            "Innogy was associating with hair, skin, and eye color.",
            "What we see are a number of skin phenotypes associated with like actinic keratosis, basal cell carcinoma's, and, Interestingly, even apparently we build for sunburns.",
            "Solar dermatitis is basically sunburns.",
            "So some people see their doctors for that."
        ],
        [
            "If we look at a use case of this, one of our G boss is was normal cardiac conduction.",
            "We found a sodium channel SCN 5 antenna associated with people with normal hearts but longer cardiac conduction and we do a few awesome that we find that's associated with atrial fibrillation.",
            "This wasn't significant statistically significant in this other population, but remember that original population did not have any arrhythmias.",
            "They were had no cardiac disease, so we went back into the original population, which at some point."
        ],
        [
            "Add normal heart and and said well what happens if we follow them over time to see if they develop atrial fibrillation and what we find is there's a dose respondent effect based on number of carriage of G alleles for developing arrhythmias.",
            "Atrial fibrillation.",
            "Specifically overtime what I like most about this graph is the X axis that we're able to go back in time and follow the patients forward for up to 20 years.",
            "After that, normal EKG and data in which they started seeing the health care system."
        ],
        [
            "So now to talk a little bit implementation.",
            "We have a program that I mentioned earlier called Predict where we prospectively Geno type 34 jeans and 100 for variance on the alumina admin platform.",
            "We come in through either a completely prospective arm which calculates your risk of receiving a target medication and the subsequent three years.",
            "And if you have a high enough risk, recommends the physician, the Geno type you or we Geno type you when you're about to get a joint replacement for which you would put on Vietnam War friend or you're going into the Cath lab.",
            "And you have a 40% likelihood of getting a stent following going into the Cath lab and then receiving clopidogrel.",
            "And it's coupled with electronic health record based decision support.",
            "We currently have 4 drug genome interactions, live computer guerrilla warfare in tacrolimus, entire purines.",
            "And you see the variance there listed.",
            "We looked at."
        ],
        [
            "To see the commonality of exposure to these medications, we looked at a medical home population, meaning they get routine care at Vanderbilt.",
            "That was 53,000 patients, and then we follow them overtime for exposure to medications with known pharmacogenetic indications as listed by FDA drug levels, and we found that 65% of patients had received at least one of these medications over five years, and so this is a General Medical population that it comes to an adult internal medicine clinic.",
            "Interestingly, one person at 18 of these medication exposures over a little bit longer than five years, 14% of them received four different medications with pharmacogenetic stories, and if you calculate the number of adverse events you could have predicted, our fraud prevented had you junior type them all, we estimate you could have prevented about 383 serious adverse events such as strokes, recurrent heart attacks or death.",
            "Our model is."
        ],
        [
            "To take those patients, we genotyped them.",
            "We get a lot of data behind that, but not all of it.",
            "Not all those genotypes in that platform.",
            "Do we know what to do with and not all of them do they work well so we only take the Geno types that work well.",
            "And for that we have good evidence for what to do with them and put that into the medical record.",
            "But the indications and the knowledge that we have grows overtime.",
            "So as we learn new information, we can push that information back into the medical record we started with just capital Grille.",
            "Then we added Warframe.",
            "We added tacrolimus.",
            "We added these different variations into the medical record overtime so genotype once you expand your decision, support overtime and this shows a screenshot of RMR we have between the allergy section and the medication section.",
            "We put their genomic variants and what it means with particular drugs.",
            "This is on the face page when you open the chart and this shows a sample of what the decision support looks like."
        ],
        [
            "Where you attempt to Oracle Pita Grill if their normal metabolizer you go on through, but if their intermediate apartment appetizer it puts up a screen that asks you suggest that maybe you should do an alternative therapy prasugrel or typographer recommended here and it also tells you some of the contraindications and what the patients value for that contraindication, such as their age and weight."
        ],
        [
            "If you look at all the patients we've tested so far, it's about 15,000 currently for clopidogrel, about 20% of them are an increased risk of MI through being either a poor metabolizer or a heterozygote intermediate metabolizer.",
            "Most people are normal, but when you look at 5 gene pairs, most people."
        ],
        [
            "Or not normal, so about 90% of patients have one variant that would change prescribing at least one variant that would change prescribing for at least one drug."
        ],
        [
            "If you look at the opportunities to use the information overtime when we did this study, we had 9600 patients we had tested.",
            "We would have you we.",
            "Those 9600 patients have been exposed to 14,000.",
            "Medications for which we have recommendations.",
            "So initially, if you look at that first block, about half the patients didn't have an initial medication for which they were genotyped.",
            "And."
        ],
        [
            "We look at prescribing decisions based on that 7400 patients.",
            "At this point, 1600 of them had a stent placed and we look at the final antiplatelet therapy and you can see the physicians are changing behavior based on the decision support that one of the strongest predictors, or whether or not they have genotyped data actually in the chart.",
            "By the time the drug is prescribed, which makes sense, it's harder to call the patient back and change their prescription.",
            "There is also a dose response effect based on whether they have two copies or one copy of loss of function, allele, 2C19."
        ],
        [
            "If you look at the cost aspect of this, this shows some rationalization behind where it might make sense in how switching and genotyping could save money.",
            "Clip it ago works well for most patients.",
            "20% of the patients we might want to change it different to a different therapy, but it's much cheaper than possible title or and quickly within less than a month you would recoup the cost of the test were you able to keep a patient on clip integrals as opposed to an alternative."
        ],
        [
            "Happy.",
            "I want to mention briefly a project that we have that's looking at next Gen sequencing to guide prescribing care.",
            "The Pharmacogenomics Research Network is a network of number of sites in the US sponsored primarily by the National Institute of General Medical Sciences who have developed a platform was hybrid depth, looking 84 pharmaka jeans.",
            "We're implementing this in Emergen about 9000 patients across those 10 sites we've genotyped are sequenced about 2000 patients.",
            "To date, and incorporating that with decision support.",
            "One of there's going to be a number of challenges with us validating next Gen platforms.",
            "Deciding what to do with rare variants and actionable variants.",
            "Addition to those that we know what to do with in the current platform."
        ],
        [
            "And with that I just want to highlight.",
            "As has been mentioned before, that personalized medicine is certainly not new.",
            "We're just having a new way to do it.",
            "We now are able to add genomic information over on top of all the other types of information that we have, and this quote by Sir William Osler is one that many of us physicians would probably memorized at some point during medical school.",
            "I want to thank them."
        ],
        [
            "The people in the teams at Vanderbilt and elsewhere across emerge and then PRN, have contributed to this work.",
            "And if you know some of these people like Dan Roden and Vanderbilt and a great team, that's been very helpful.",
            "So with that thank you very much for your time.",
            "Two questions, the first is in terms of actionable variants and and you gave the example of computer going to see 1950% are still not taking it up in terms of changing the prescribing decision.",
            "Have you tried to find out why they're not changing it?",
            "Do they just not believe the story or they feel that there's just not enough evidence?",
            "So be quiet.",
            "You know why I'm the second issue is presumably you are following those patients suffer lanja tude.",
            "Where decision was made to change the drug therapy have used.",
            "How long are you going to follow them off for and have you done some kind of sample size calculation?",
            "How many you need to actually show that the change in prescribing Cousin actually variant actually lead to changing the palka great questions.",
            "So the first question, one of the interesting points is the few and some of those patients have contraindications possible age prior strokes, things like that press rule being the primary agent during this time.",
            "And if you remove those patients, about 70% of the poor metabolizers have switched, but there's a great degree great influence by the physician based on who gets switched.",
            "So some physicians clearly probably don't believe it, or they just don't feel like they can be troubled to think about it.",
            "Or maybe they're avoiding electronic prescribing too.",
            "Maybe they're using script pads more often than other providers are, so they're not getting the alerts like the other patients are then.",
            "In terms of outcomes, since it isn't a char, we are of course looking at that.",
            "So it will be hard to show to have the power to actually show a difference.",
            "I think if you look at the sample size calculations so far though, we can see that our major adverse cardiac events in this population that has data so far is in the form of laws were group that switched is equal to the normal tab lasers.",
            "So less than what you would expect based on research studies.",
            "So it does actually look like we might be trending towards that.",
            "What you'd hoped would happen in terms of outcomes.",
            "But we will need more data and more analysis.",
            "OK, any other questions, comments?",
            "So thank you very much, Josh, as we need to move on."
        ]
    ],
    "summarization": {
        "clip_0": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is a slide that we use a lot of the interval.",
                    "label": 0
                },
                {
                    "sent": "It is from The New Yorker in 2000 and here we have a lady presenting her sequence on a piece of paper which I think is probably not going to be.",
                    "label": 0
                },
                {
                    "sent": "We're doing to a pharmacist who we I think, looks rather befuddled, and array of medications kind of Askew on the floor as well.",
                    "label": 0
                },
                {
                    "sent": "So kind of representing some of the challenges here, even a decade before we started to think about actually doing this.",
                    "label": 0
                },
                {
                    "sent": "So how do we actually move this towards reality?",
                    "label": 0
                },
                {
                    "sent": "And so we start with.",
                    "label": 0
                }
            ]
        },
        "clip_1": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Foundation of biomedical research.",
                    "label": 0
                },
                {
                    "sent": "Ann, I think what I'm going to demonstrate today, it is really a focus on information technology and the importance of that as well.",
                    "label": 0
                },
                {
                    "sent": "And then our model has been to really use the healthcare system as a system for discovery and then the important aspect of that is to adapt the healthcare system as you learn new data to revise and incorporate and obviously feedback into your research are doing and the IT solutions you create.",
                    "label": 0
                }
            ]
        },
        "clip_2": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So in everything I'm going to talk about today, the electronic health Record or HR is feeding discovery an implementation.",
                    "label": 0
                },
                {
                    "sent": "So on the left we have the discovery side and that system that we're going to talk about uses a repository called Bio View, which is a D identified DNA repository for which all the phenotypic information essentially comes from the electronic health record.",
                    "label": 0
                },
                {
                    "sent": "On the other side is implementation ARM, which will get in towards the latter half of the talk.",
                    "label": 0
                },
                {
                    "sent": "That system is called predict.",
                    "label": 0
                },
                {
                    "sent": "Where we do CLIA certified, which is the US based validation for laboratory testing.",
                    "label": 0
                },
                {
                    "sent": "And then we have integrated decision support in the HR.",
                    "label": 0
                },
                {
                    "sent": "This is in the clinical record.",
                    "label": 0
                },
                {
                    "sent": "The two systems are separated and we don't know what happens in Bio View.",
                    "label": 0
                },
                {
                    "sent": "We don't see that in the clinical side.",
                    "label": 0
                },
                {
                    "sent": "So these are two sides of this talk and discovering implementation.",
                    "label": 0
                }
            ]
        },
        "clip_3": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Have you as an opt out DNA Biobank relies on the principle of establishing the code of federal regulations in the US that allows you to use deidentified samples for research.",
                    "label": 0
                },
                {
                    "sent": "We, in addition to that, have an opt out clause and it was guided by four years of work before we started Bio View with surveys with discussions with the federal government and focus groups as well as discussions with ethicist and lawyers.",
                    "label": 0
                },
                {
                    "sent": "And the model is that we have before above the signature line in this consent to treatment form that everyone signs in a yearly basis that says we can bill your insurance company and that sort of thing that they say that they have to check this box in order to not be part of the DNA biobank In addition, there are signs there.",
                    "label": 0
                },
                {
                    "sent": "We've surveyed how many people are aware of the system as well.",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                }
            ]
        },
        "clip_4": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This is now an electronic screen and has been for the last few years.",
                    "label": 0
                },
                {
                    "sent": "Our survey suggested that the opt out rate would be about 5 to 10% per year.",
                    "label": 0
                },
                {
                    "sent": "It's been about that through the life of the program.",
                    "label": 0
                },
                {
                    "sent": "The lifetime opt out rate is about 15% and we treat at once.",
                    "label": 0
                },
                {
                    "sent": "Opt out isn't always opt out, assuming that maybe they just forget to check the form in subsec.",
                    "label": 0
                }
            ]
        },
        "clip_5": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Years, so the models we take the medical record we put the medical record number through a one way hash with the seed, which which is a unidirectional mapping.",
                    "label": 0
                },
                {
                    "sent": "So we can't go backwards with it, and then we scrub all the personal health identifiers from the medical record and that is what we call a synthetic derivative.",
                    "label": 0
                },
                {
                    "sent": "It has about 2.2 million records and we can update it regularly because the hash always takes the same number forward.",
                    "label": 0
                },
                {
                    "sent": "Similarly, we have a clinical blood sample that's scheduled to be discarded.",
                    "label": 0
                },
                {
                    "sent": "We check to see if they are eligible, meaning they haven't opted out.",
                    "label": 0
                },
                {
                    "sent": "We also exclude a random percentage of people each day so that we don't know for sure, even if you haven't opted out, that you're in the system and then we would extract the DNA from that and bank that and currently by of you has about 180,000 DNA samples.",
                    "label": 0
                }
            ]
        },
        "clip_6": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The creating the synthetic driven in the sources of information we have is quite a lot, and this is actually simplified to the data sources we use.",
                    "label": 0
                },
                {
                    "sent": "Most of them come from the medical record we have the laboratory that radiology test.",
                    "label": 0
                },
                {
                    "sent": "These sorts of things electronic in some cases back into the 1980s.",
                    "label": 0
                },
                {
                    "sent": "We have clinical notes, full text notes robustly across inpatient outpatient since the early 2000s, and we actually go further back than that in a lot of sources, and we have electronic prescribing.",
                    "label": 0
                },
                {
                    "sent": "In our hospital since the 1990s and then we also combine an external registry such as tumor registries, cardiothoracic registries that are maintained on a research basis, and we can map those in as well.",
                    "label": 0
                },
                {
                    "sent": "We need to do things to structure this data better than what would happen by default, and so we employ techniques that we've developed in House such as natural language processing which can identify, for instance, medication names, doses, routes, frequencies from free text documents.",
                    "label": 0
                },
                {
                    "sent": "We can also map concepts like congestive heart failure in CHF and disambiguate weather.",
                    "label": 0
                },
                {
                    "sent": "CHF means congestive heart failure or Crimean hemorrhagic fever, which doesn't happen too often in the United States, but we can.",
                    "label": 0
                },
                {
                    "sent": "We can do those sorts of mappings as well.",
                    "label": 0
                },
                {
                    "sent": "We can also determine what happened to the patient or to the mom.",
                    "label": 0
                },
                {
                    "sent": "All that stuff from the natural language and then we can feed that into structured databases for querying subsequently.",
                    "label": 0
                },
                {
                    "sent": "When we started this.",
                    "label": 0
                }
            ]
        },
        "clip_7": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We decided we needed a demonstration project to show it actually worked and this is we picked 5 diseases with 21 genetic variants at that time were known.",
                    "label": 0
                },
                {
                    "sent": "We genotyped the first 10,000 patients in the Bio View and then we used electronic algorithms to find patients with those diseases.",
                    "label": 0
                },
                {
                    "sent": "Red squares represent the public odds ratios for these snip phenotype combinations.",
                    "label": 0
                },
                {
                    "sent": "The blue diamonds represent the odds ratios we found in Bio View.",
                    "label": 0
                },
                {
                    "sent": "Notably, most of the confidence intervals overlap.",
                    "label": 0
                },
                {
                    "sent": "We didn't have any snip phenotype associations that went the opposite direction, thinking they were protected versus risk factor, and depending on how you do statistical analysis, what kind of genetic model you assume we replicate 8 to 9 of the 21 associations.",
                    "label": 0
                },
                {
                    "sent": "I've note we were underpowered for almost all these associations, and it highlights one of the challenges to doing genomic work is at L. You know that you need large sample sizes and 10,000 patients of a General Medical accrual situation was not a lot of the time.",
                    "label": 0
                },
                {
                    "sent": "For instance, we had 66 patients with multiple sclerosis.",
                    "label": 0
                },
                {
                    "sent": "So what we found.",
                    "label": 0
                }
            ]
        },
        "clip_8": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "In this process of of, how do we find who has what disease?",
                    "label": 0
                },
                {
                    "sent": "Was that it requires multiple sources of information?",
                    "label": 0
                },
                {
                    "sent": "So we start with billing codes which are kind of necessary but not sufficient, and then we overlay on top of it.",
                    "label": 0
                },
                {
                    "sent": "Things like clinical notes and natural language processing.",
                    "label": 0
                },
                {
                    "sent": "Medication data is very helpful too, as a marker of both disease status and severity of disease and then laboratory and test results are often important as well.",
                    "label": 0
                },
                {
                    "sent": "And the general process is some sort of algorithm combining these.",
                    "label": 0
                },
                {
                    "sent": "Usually it's kind of Boolean logic and or not.",
                    "label": 0
                },
                {
                    "sent": "Kind of combinations and doing things like counts and sometimes temporal relationships allow us to get it true cases.",
                    "label": 0
                },
                {
                    "sent": "We start with identifying a phenotype of interest.",
                    "label": 0
                },
                {
                    "sent": "We find that it's an iterative process where we think through what the phenotype should look like, and we manually review a set of records.",
                    "label": 0
                },
                {
                    "sent": "Then we evolve our algorithm until we get a sufficient positive friction value.",
                    "label": 0
                },
                {
                    "sent": "Reviewing different sets of cases each time.",
                    "label": 0
                },
                {
                    "sent": "We don't just test the same patients each time to avoid what we've called over fitting in the machine learning world.",
                    "label": 0
                },
                {
                    "sent": "And then we deploy in our DNA biobank and we can also deploy those and other bio banks as well.",
                    "label": 0
                },
                {
                    "sent": "We've shown these algorithms are generally portable to other electronic health record systems and then we perform genetic Association tests.",
                    "label": 0
                },
                {
                    "sent": "Development of the phenotype algorithm becomes the arduous part that takes the most time in today's analysis and that can take 6 to 18 months to get that right.",
                    "label": 0
                }
            ]
        },
        "clip_9": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We are part of a large network called the Emerge Network Electronic Medical Records in Genomics.",
                    "label": 0
                },
                {
                    "sent": "It's funded by national Human Genome Research Institute.",
                    "label": 0
                },
                {
                    "sent": "It now includes rtinsights across the US and there are other sites in both the US in the world that have electronic medical records linked to DNA biobanks.",
                    "label": 0
                },
                {
                    "sent": "Our goals and emerge were initially to perform GWAS is based on a char data.",
                    "label": 0
                },
                {
                    "sent": "It is extended to implement as well.",
                    "label": 0
                }
            ]
        },
        "clip_10": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "That one of these studies we've done many of them, but one that I'll highlight was the first project that used just leftover genetic data and populations of patients that had been genotyped for other reasons.",
                    "label": 0
                },
                {
                    "sent": "So we picked a relatively common phenotype, autoimmune hypothyroidism, and we look for those amongst people that were genotyped for things like cardiac conduction or dementia, cataracts.",
                    "label": 0
                },
                {
                    "sent": "These different phenotypes across these five different emerged sites.",
                    "label": 0
                },
                {
                    "sent": "We developed an algorithm at Vanderbilt.",
                    "label": 0
                },
                {
                    "sent": "Then we distributed to the other.",
                    "label": 0
                },
                {
                    "sent": "Emerge sites at that time there were total of five, and they implemented the same algorithm and validated it and it worked well at all five sites.",
                    "label": 0
                },
                {
                    "sent": "There is one outlier, an that with a positive value in the mid 80s and that was due to the fact that they had a lot of patients in their population that were sort of flying in for subspecialty care as opposed to getting general routine care at center.",
                    "label": 0
                },
                {
                    "sent": "We found a novel.",
                    "label": 0
                }
            ]
        },
        "clip_11": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "No, it's a thyroid transcription signal called Foxy one on chromosome 9 that was associated with hypothyroidism and and this was replicated in a subsequent population and it's been replicated by subsequent jiwa.",
                    "label": 0
                }
            ]
        },
        "clip_12": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This summarizes some of the other Jiwa says we have been done.",
                    "label": 0
                },
                {
                    "sent": "The bold phenotypes represent phenotypes for which we had genome wide significant signals.",
                    "label": 0
                },
                {
                    "sent": "The ones with the new stars beside them represent ones that we had novel findings for those phenotypes.",
                    "label": 0
                },
                {
                    "sent": "In addition to these 20 or so phenotypes I've listed there an additional 30 G boss is in progress as part of the Merge 2.",
                    "label": 0
                },
                {
                    "sent": "And yesterday's.",
                    "label": 0
                }
            ]
        },
        "clip_13": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Presentation talked about the PCs Key Nine story and I wanted to just highlight the the ability to do these kinds of studies, potentially very rapidly in the HR.",
                    "label": 0
                },
                {
                    "sent": "So in yesterday's presentation of Keena, we heard about the rare variants in PCs.",
                    "label": 0
                },
                {
                    "sent": "Canine influencing people with very low LDL levels and then for being protective against cardiac events.",
                    "label": 0
                },
                {
                    "sent": "So if you look at the distribution of LDL values in Bio view, we find that we actually have 150 people.",
                    "label": 0
                },
                {
                    "sent": "They have LDLS less than 50 amongst people that actually have genetic data, so this shows you the distribution of the LDL values, and then if you do, we've done our very large population with the this exome chip, which looks at coding variants and happens to have the R 46 L variant, which was the stronger signal in that New England Journal paper that he presented yesterday.",
                    "label": 0
                },
                {
                    "sent": "An if you look at just taking the general population, we genotyped, 150 of them had these very low LDL values.",
                    "label": 0
                },
                {
                    "sent": "You can see that we very strongly replicate.",
                    "label": 0
                },
                {
                    "sent": "That known signal with PCs K9 in a population that was not genotyped for this purpose.",
                    "label": 0
                }
            ]
        },
        "clip_14": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So that highlights the ability to do this kind of study on the HR.",
                    "label": 0
                },
                {
                    "sent": "We've moved on to look at G. Watts is with.",
                    "label": 0
                },
                {
                    "sent": "For drug response phenotypes, this was called our Vesper project as part of a grant was called a Grand opportunities grant during the bolus of funding that went into the NIH and our goal was to sequence or sorry Geno, type through juos level genotyping.",
                    "label": 0
                },
                {
                    "sent": "About 10,000 people within that we were able to identify 31 pharmacogenetic traits to investigate and we developed phenotype algorithms for these different algorithms.",
                    "label": 0
                },
                {
                    "sent": "The first 2.",
                    "label": 0
                },
                {
                    "sent": "Womans we looked at in greenware replications of known associations.",
                    "label": 0
                },
                {
                    "sent": "We talked a lot about warfare in this morning.",
                    "label": 0
                },
                {
                    "sent": "And computer goes into effect as well, and then the rest are discovered phenotypes, notably amongst those phenotypes 5th.",
                    "label": 0
                }
            ]
        },
        "clip_15": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "5% of the cases or controls were also participated in another phenotype, so that shows the efficiency of using Jiwa samples.",
                    "label": 0
                },
                {
                    "sent": "I'm sorry EMR samples because they can participate in multiple phenotypes as one might expect, 'cause we all often are accrued different diseases overtime.",
                    "label": 0
                },
                {
                    "sent": "If you look at capital grille Pickles, a prodrug is activated by CYP 217, primarily in the two Oxo, clopidogrel and studies have shown that two C 19 poor metabolizers aren't increased likelihood of having recurrent cardiovascular events.",
                    "label": 0
                },
                {
                    "sent": "We developed an algorithm that did require some manual review to assure compliance with clopidogrel at the time of the subsequent event.",
                    "label": 0
                },
                {
                    "sent": "Nonetheless, our algorithm was fairly accurate and you can see and certainly speed up the process of finding these patients.",
                    "label": 0
                },
                {
                    "sent": "You can see that poor in metabolizers, where decrease incidence for having cardiovascular events similarly in reference to.",
                    "label": 0
                }
            ]
        },
        "clip_16": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Excellent talk this morning and warfare and I wanted to highlight some of the work we've done with your friend.",
                    "label": 0
                },
                {
                    "sent": "This shows the percent variation that we are able to explain with different algorithms using EMR derived algorithm and what we found is that the clinical genomic algorithms for European Americans routinely did better than the clinical algorithms.",
                    "label": 0
                },
                {
                    "sent": "But in African Americans, as you might expect, there's more similarity between the genetic algorithms and the clinical algorithms.",
                    "label": 0
                },
                {
                    "sent": "If you expand the number of variants, you get an improved.",
                    "label": 0
                },
                {
                    "sent": "Result.",
                    "label": 0
                },
                {
                    "sent": "This shows two phenotypes for which we have new discoveries.",
                    "label": 0
                }
            ]
        },
        "clip_17": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Which both have some degree of replication.",
                    "label": 0
                },
                {
                    "sent": "ACE inhibitors, one of the most common side effects, is cough, and we identified a significant signal there which is also associated with asthma.",
                    "label": 0
                },
                {
                    "sent": "These samples are adjusted for asthma and heparin induced.",
                    "label": 0
                },
                {
                    "sent": "Armed with Sandy pina.",
                    "label": 0
                },
                {
                    "sent": "Very rare but severe outcome with high morbidity that is a T cell receptor gene.",
                    "label": 0
                },
                {
                    "sent": "And Interestingly you have to be recessive homozygote to have the increased risk of the effect.",
                    "label": 0
                }
            ]
        },
        "clip_18": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So this tells you the idea of doing jiwa's in the electronic medical record.",
                    "label": 0
                },
                {
                    "sent": "There's also the ability to do what we call Phenome Wide Association study, which does the inverse study, starting with the genotyped looking at many phenotypes and to do this really requires a densely phenotype record, something we have in electronic health records, but are not necessarily common observation.",
                    "label": 0
                },
                {
                    "sent": "ULL studies.",
                    "label": 0
                },
                {
                    "sent": "So as a large scale study of this, if you look at all the Geno types.",
                    "label": 0
                }
            ]
        },
        "clip_19": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Discovered through G was there at this time when we did the study, there were about 3100 snips that prior associations.",
                    "label": 0
                },
                {
                    "sent": "If you map those two disease phenotypes available in the HR at 751 individual snips and phenotypes had significant associations, and we look for replication using the HR.",
                    "label": 0
                },
                {
                    "sent": "We also looked at these for new discoveries.",
                    "label": 0
                }
            ]
        },
        "clip_20": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "This shows a replication data.",
                    "label": 0
                },
                {
                    "sent": "Each point represents a single snip associated with a given phenotype.",
                    "label": 0
                },
                {
                    "sent": "Overall, testing 86 phenotypes and what you can see is we're able to replicate meaning to the right of that light blue line.",
                    "label": 0
                },
                {
                    "sent": "A number of snip phenotype Association pairs across a number of different disease categories in this very rapid phenotype model using FiOS, the phenotypes aren't as accurate as the ones that we do in other methods where we carefully design it, but it allows us to quickly survey for new associations.",
                    "label": 0
                },
                {
                    "sent": "Overall, we represent replicated 210 of those 751.",
                    "label": 0
                },
                {
                    "sent": "If you look at those for which we had adequate case sizes, we replicated 51 out of 77 of the phenotypes.",
                    "label": 0
                }
            ]
        },
        "clip_21": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If you look at all the results we found on these 3000 snips, these are the results mapped to chromosome location, each diamond representing a single unique phenotype with that Association.",
                    "label": 0
                },
                {
                    "sent": "So what you see is there differential pleiotropy that we have found at different parts of the genome and different locations and snips which we would expect to find the blue represent new associations that represent things that have been discovered before that we didn't replicate in green represent prior discoveries that we did.",
                    "label": 0
                },
                {
                    "sent": "Replicate and if I just zoom in a couple locations to, llamas were first transcriptase.",
                    "label": 0
                },
                {
                    "sent": "At the time was known associations glioma.",
                    "label": 0
                },
                {
                    "sent": "We found associations with separated keratosis and leukoplakia and.",
                    "label": 0
                }
            ]
        },
        "clip_22": {
            "is_summarization_sample": true,
            "summarization_data": [
                {
                    "sent": "And one of the most pleiotropic snips was IRF 4, which was done in discovered.",
                    "label": 0
                },
                {
                    "sent": "Innogy was associating with hair, skin, and eye color.",
                    "label": 1
                },
                {
                    "sent": "What we see are a number of skin phenotypes associated with like actinic keratosis, basal cell carcinoma's, and, Interestingly, even apparently we build for sunburns.",
                    "label": 0
                },
                {
                    "sent": "Solar dermatitis is basically sunburns.",
                    "label": 0
                },
                {
                    "sent": "So some people see their doctors for that.",
                    "label": 0
                }
            ]
        },
        "clip_23": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If we look at a use case of this, one of our G boss is was normal cardiac conduction.",
                    "label": 0
                },
                {
                    "sent": "We found a sodium channel SCN 5 antenna associated with people with normal hearts but longer cardiac conduction and we do a few awesome that we find that's associated with atrial fibrillation.",
                    "label": 0
                },
                {
                    "sent": "This wasn't significant statistically significant in this other population, but remember that original population did not have any arrhythmias.",
                    "label": 0
                },
                {
                    "sent": "They were had no cardiac disease, so we went back into the original population, which at some point.",
                    "label": 0
                }
            ]
        },
        "clip_24": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Add normal heart and and said well what happens if we follow them over time to see if they develop atrial fibrillation and what we find is there's a dose respondent effect based on number of carriage of G alleles for developing arrhythmias.",
                    "label": 0
                },
                {
                    "sent": "Atrial fibrillation.",
                    "label": 0
                },
                {
                    "sent": "Specifically overtime what I like most about this graph is the X axis that we're able to go back in time and follow the patients forward for up to 20 years.",
                    "label": 0
                },
                {
                    "sent": "After that, normal EKG and data in which they started seeing the health care system.",
                    "label": 0
                }
            ]
        },
        "clip_25": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "So now to talk a little bit implementation.",
                    "label": 0
                },
                {
                    "sent": "We have a program that I mentioned earlier called Predict where we prospectively Geno type 34 jeans and 100 for variance on the alumina admin platform.",
                    "label": 0
                },
                {
                    "sent": "We come in through either a completely prospective arm which calculates your risk of receiving a target medication and the subsequent three years.",
                    "label": 0
                },
                {
                    "sent": "And if you have a high enough risk, recommends the physician, the Geno type you or we Geno type you when you're about to get a joint replacement for which you would put on Vietnam War friend or you're going into the Cath lab.",
                    "label": 0
                },
                {
                    "sent": "And you have a 40% likelihood of getting a stent following going into the Cath lab and then receiving clopidogrel.",
                    "label": 0
                },
                {
                    "sent": "And it's coupled with electronic health record based decision support.",
                    "label": 0
                },
                {
                    "sent": "We currently have 4 drug genome interactions, live computer guerrilla warfare in tacrolimus, entire purines.",
                    "label": 0
                },
                {
                    "sent": "And you see the variance there listed.",
                    "label": 0
                },
                {
                    "sent": "We looked at.",
                    "label": 0
                }
            ]
        },
        "clip_26": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To see the commonality of exposure to these medications, we looked at a medical home population, meaning they get routine care at Vanderbilt.",
                    "label": 0
                },
                {
                    "sent": "That was 53,000 patients, and then we follow them overtime for exposure to medications with known pharmacogenetic indications as listed by FDA drug levels, and we found that 65% of patients had received at least one of these medications over five years, and so this is a General Medical population that it comes to an adult internal medicine clinic.",
                    "label": 0
                },
                {
                    "sent": "Interestingly, one person at 18 of these medication exposures over a little bit longer than five years, 14% of them received four different medications with pharmacogenetic stories, and if you calculate the number of adverse events you could have predicted, our fraud prevented had you junior type them all, we estimate you could have prevented about 383 serious adverse events such as strokes, recurrent heart attacks or death.",
                    "label": 0
                },
                {
                    "sent": "Our model is.",
                    "label": 0
                }
            ]
        },
        "clip_27": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "To take those patients, we genotyped them.",
                    "label": 0
                },
                {
                    "sent": "We get a lot of data behind that, but not all of it.",
                    "label": 0
                },
                {
                    "sent": "Not all those genotypes in that platform.",
                    "label": 0
                },
                {
                    "sent": "Do we know what to do with and not all of them do they work well so we only take the Geno types that work well.",
                    "label": 0
                },
                {
                    "sent": "And for that we have good evidence for what to do with them and put that into the medical record.",
                    "label": 0
                },
                {
                    "sent": "But the indications and the knowledge that we have grows overtime.",
                    "label": 0
                },
                {
                    "sent": "So as we learn new information, we can push that information back into the medical record we started with just capital Grille.",
                    "label": 0
                },
                {
                    "sent": "Then we added Warframe.",
                    "label": 0
                },
                {
                    "sent": "We added tacrolimus.",
                    "label": 0
                },
                {
                    "sent": "We added these different variations into the medical record overtime so genotype once you expand your decision, support overtime and this shows a screenshot of RMR we have between the allergy section and the medication section.",
                    "label": 0
                },
                {
                    "sent": "We put their genomic variants and what it means with particular drugs.",
                    "label": 0
                },
                {
                    "sent": "This is on the face page when you open the chart and this shows a sample of what the decision support looks like.",
                    "label": 0
                }
            ]
        },
        "clip_28": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Where you attempt to Oracle Pita Grill if their normal metabolizer you go on through, but if their intermediate apartment appetizer it puts up a screen that asks you suggest that maybe you should do an alternative therapy prasugrel or typographer recommended here and it also tells you some of the contraindications and what the patients value for that contraindication, such as their age and weight.",
                    "label": 0
                }
            ]
        },
        "clip_29": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If you look at all the patients we've tested so far, it's about 15,000 currently for clopidogrel, about 20% of them are an increased risk of MI through being either a poor metabolizer or a heterozygote intermediate metabolizer.",
                    "label": 0
                },
                {
                    "sent": "Most people are normal, but when you look at 5 gene pairs, most people.",
                    "label": 0
                }
            ]
        },
        "clip_30": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Or not normal, so about 90% of patients have one variant that would change prescribing at least one variant that would change prescribing for at least one drug.",
                    "label": 0
                }
            ]
        },
        "clip_31": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If you look at the opportunities to use the information overtime when we did this study, we had 9600 patients we had tested.",
                    "label": 0
                },
                {
                    "sent": "We would have you we.",
                    "label": 0
                },
                {
                    "sent": "Those 9600 patients have been exposed to 14,000.",
                    "label": 0
                },
                {
                    "sent": "Medications for which we have recommendations.",
                    "label": 0
                },
                {
                    "sent": "So initially, if you look at that first block, about half the patients didn't have an initial medication for which they were genotyped.",
                    "label": 0
                },
                {
                    "sent": "And.",
                    "label": 0
                }
            ]
        },
        "clip_32": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "We look at prescribing decisions based on that 7400 patients.",
                    "label": 0
                },
                {
                    "sent": "At this point, 1600 of them had a stent placed and we look at the final antiplatelet therapy and you can see the physicians are changing behavior based on the decision support that one of the strongest predictors, or whether or not they have genotyped data actually in the chart.",
                    "label": 0
                },
                {
                    "sent": "By the time the drug is prescribed, which makes sense, it's harder to call the patient back and change their prescription.",
                    "label": 0
                },
                {
                    "sent": "There is also a dose response effect based on whether they have two copies or one copy of loss of function, allele, 2C19.",
                    "label": 0
                }
            ]
        },
        "clip_33": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "If you look at the cost aspect of this, this shows some rationalization behind where it might make sense in how switching and genotyping could save money.",
                    "label": 0
                },
                {
                    "sent": "Clip it ago works well for most patients.",
                    "label": 0
                },
                {
                    "sent": "20% of the patients we might want to change it different to a different therapy, but it's much cheaper than possible title or and quickly within less than a month you would recoup the cost of the test were you able to keep a patient on clip integrals as opposed to an alternative.",
                    "label": 0
                }
            ]
        },
        "clip_34": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "Happy.",
                    "label": 0
                },
                {
                    "sent": "I want to mention briefly a project that we have that's looking at next Gen sequencing to guide prescribing care.",
                    "label": 0
                },
                {
                    "sent": "The Pharmacogenomics Research Network is a network of number of sites in the US sponsored primarily by the National Institute of General Medical Sciences who have developed a platform was hybrid depth, looking 84 pharmaka jeans.",
                    "label": 0
                },
                {
                    "sent": "We're implementing this in Emergen about 9000 patients across those 10 sites we've genotyped are sequenced about 2000 patients.",
                    "label": 0
                },
                {
                    "sent": "To date, and incorporating that with decision support.",
                    "label": 0
                },
                {
                    "sent": "One of there's going to be a number of challenges with us validating next Gen platforms.",
                    "label": 0
                },
                {
                    "sent": "Deciding what to do with rare variants and actionable variants.",
                    "label": 0
                },
                {
                    "sent": "Addition to those that we know what to do with in the current platform.",
                    "label": 0
                }
            ]
        },
        "clip_35": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "And with that I just want to highlight.",
                    "label": 0
                },
                {
                    "sent": "As has been mentioned before, that personalized medicine is certainly not new.",
                    "label": 0
                },
                {
                    "sent": "We're just having a new way to do it.",
                    "label": 0
                },
                {
                    "sent": "We now are able to add genomic information over on top of all the other types of information that we have, and this quote by Sir William Osler is one that many of us physicians would probably memorized at some point during medical school.",
                    "label": 0
                },
                {
                    "sent": "I want to thank them.",
                    "label": 0
                }
            ]
        },
        "clip_36": {
            "is_summarization_sample": false,
            "summarization_data": [
                {
                    "sent": "The people in the teams at Vanderbilt and elsewhere across emerge and then PRN, have contributed to this work.",
                    "label": 0
                },
                {
                    "sent": "And if you know some of these people like Dan Roden and Vanderbilt and a great team, that's been very helpful.",
                    "label": 0
                },
                {
                    "sent": "So with that thank you very much for your time.",
                    "label": 0
                },
                {
                    "sent": "Two questions, the first is in terms of actionable variants and and you gave the example of computer going to see 1950% are still not taking it up in terms of changing the prescribing decision.",
                    "label": 0
                },
                {
                    "sent": "Have you tried to find out why they're not changing it?",
                    "label": 0
                },
                {
                    "sent": "Do they just not believe the story or they feel that there's just not enough evidence?",
                    "label": 0
                },
                {
                    "sent": "So be quiet.",
                    "label": 0
                },
                {
                    "sent": "You know why I'm the second issue is presumably you are following those patients suffer lanja tude.",
                    "label": 0
                },
                {
                    "sent": "Where decision was made to change the drug therapy have used.",
                    "label": 0
                },
                {
                    "sent": "How long are you going to follow them off for and have you done some kind of sample size calculation?",
                    "label": 0
                },
                {
                    "sent": "How many you need to actually show that the change in prescribing Cousin actually variant actually lead to changing the palka great questions.",
                    "label": 0
                },
                {
                    "sent": "So the first question, one of the interesting points is the few and some of those patients have contraindications possible age prior strokes, things like that press rule being the primary agent during this time.",
                    "label": 0
                },
                {
                    "sent": "And if you remove those patients, about 70% of the poor metabolizers have switched, but there's a great degree great influence by the physician based on who gets switched.",
                    "label": 0
                },
                {
                    "sent": "So some physicians clearly probably don't believe it, or they just don't feel like they can be troubled to think about it.",
                    "label": 0
                },
                {
                    "sent": "Or maybe they're avoiding electronic prescribing too.",
                    "label": 0
                },
                {
                    "sent": "Maybe they're using script pads more often than other providers are, so they're not getting the alerts like the other patients are then.",
                    "label": 0
                },
                {
                    "sent": "In terms of outcomes, since it isn't a char, we are of course looking at that.",
                    "label": 0
                },
                {
                    "sent": "So it will be hard to show to have the power to actually show a difference.",
                    "label": 0
                },
                {
                    "sent": "I think if you look at the sample size calculations so far though, we can see that our major adverse cardiac events in this population that has data so far is in the form of laws were group that switched is equal to the normal tab lasers.",
                    "label": 0
                },
                {
                    "sent": "So less than what you would expect based on research studies.",
                    "label": 0
                },
                {
                    "sent": "So it does actually look like we might be trending towards that.",
                    "label": 0
                },
                {
                    "sent": "What you'd hoped would happen in terms of outcomes.",
                    "label": 0
                },
                {
                    "sent": "But we will need more data and more analysis.",
                    "label": 0
                },
                {
                    "sent": "OK, any other questions, comments?",
                    "label": 0
                },
                {
                    "sent": "So thank you very much, Josh, as we need to move on.",
                    "label": 0
                }
            ]
        }
    }
}